Chest Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by STEININGER, W. J.
Right arrow Articles by HOWARD, W. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by STEININGER, W. J.
Right arrow Articles by HOWARD, W. L.
(Chest. 1955;28:177-187.)
© 1955 American College of Chest Physicians

Long Term Antimicrobial Therapy Without Collapse: 300 Cases of Pulmonary Tuberculosis Treated for One Year or Longer

W. J. STEININGER M.D.1 and W. L. HOWARD M.D., F.C.C.P.1

1 The William H. Maybury Sanatorium, Northville, Michigan.

The advancing age of sanatorium populations carries with it definite clinical problems. Since 1951 at Maybury Sanatorium, 137 poor prognosis, salvage patients have been treated with long-term antimicrobials. They were older white males, for the most part, with far advanced fibrocavernous disease of long standing. Results are compared with 163 similarly treated patients with less destructive disease of shorter duration. As regards cavity closure, x-ray improvement and time of discharge, the salvage group lagged far behind the nonsalvage. But in sputum conversion, the salvage group was only slightly less impressive. The achievement of stable roentgenograms, negative sputum cultures and acceptable clinical status in over three-fourths of their number justifies the prolonged use of antimicrobials in individuals with apparently poor prognosis. For the patient whose disease has stabilized but still is of such major proportion that therapy must be extended indefinitely, the concept of a maintenance dose is introduced. Such therapy in selected cases is a promising means of preserving therapeutic gains.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1955 by the American College of Chest Physicians.